SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Clinical trial NCT06562647 · RECRUITING
Trial details
- NCT number
- NCT06562647
- Sponsor
- Cell Origin Biotech (Hangzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2026-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.